Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Watters

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontline Gastroenterology|October 19, 2023
Heart was the key to the diagnosisKhawaja Junaid Akhtar, Tina Maheswaran, Christopher Watters
Frontline Gastroenterology|October 26, 2017
Collagenous panenteritis: a rare cause of chronic diarrhoeaSandev Singh, Larry Ee Juan Loo, Christopher Watters, et al.
Future Healthcare Journal|May 18, 2019
Core medical training, not core medical service provisionOrod Osanlou, Frederick Frost, Rebecca Shaw, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2020
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's diseaseTristan Townsend, Violeta Razanskaite, Susanna Dodd, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontline Gastroenterology|October 19, 2023
Heart was the key to the diagnosisKhawaja Junaid Akhtar, Tina Maheswaran, Christopher Watters
Frontline Gastroenterology|October 26, 2017
Collagenous panenteritis: a rare cause of chronic diarrhoeaSandev Singh, Larry Ee Juan Loo, Christopher Watters, et al.
Future Healthcare Journal|May 18, 2019
Core medical training, not core medical service provisionOrod Osanlou, Frederick Frost, Rebecca Shaw, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2020
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's diseaseTristan Townsend, Violeta Razanskaite, Susanna Dodd, et al.
Pageof 2